MedTrace Logo

Data Collection and Evaluation of OptiBP Under Investigational Use

NCT06017687 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500000

Last updated 2023-09-29

No results posted yet for this study

Summary

The purpose of this study is to collect data to develop and evaluate the use of state-of-the-art machine learning approaches within a mobile phone application for the estimation of blood pressure.

Conditions

  • General Population

Interventions

DEVICE

OptiBP Study app

Each participant will use OptiBP Study app to measure their blood pressure optically by applying their fingertip to their smartphone camera, and subsequently enter the blood pressure values obtained by measuring it with their own blood pressure cuff.

Sponsors & Collaborators

  • Biospectal

    lead INDUSTRY

Principal Investigators

  • Frederic Frappereau · Biospectal

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-28
Primary Completion
2024-09-30
Completion
2026-09-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06017687 on ClinicalTrials.gov